1 |
Wang ZX, Cao JX, Liu ZP, et al (2014). Combination of chemotherapy and immnotherapy for colon cancer in China: A meta-analysis. World J Gastroenterol, 20, 1095-106.
DOI
ScienceOn
|
2 |
Sandel MH, Speetjens FM, Menon AG, et al (2005). Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol, 42, 541-6.
DOI
ScienceOn
|
3 |
Siddle HV, Kreiss A, Tovar C, et al (2013). Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. Proc Natl Acad Sci USA, 110, 5103-8.
DOI
ScienceOn
|
4 |
Stella GM, Luisetti M, Pozzi E, et al (2013). Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. Lancet Respir Med, 1, 251-61.
DOI
ScienceOn
|
5 |
Xu Y, Wang M (2014). Progress in immunotherapy for non-small cell lung Cancer. Zhongguo Fei Ai Za Zhi, 17, 34-41.
|
6 |
Ye L, Fan J, Shi X, et al (2014). Tumor necrosis therapy antibody interleukin-2 fusion protein elicits prolonged and targeted antitumor effects in vivo. Appl Microbiol Biotechnol, 98, 4053-61.
DOI
ScienceOn
|
7 |
Yuan CH, Yang XQ, Zhu CL, et al (2014). Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model. Asian Pac J Cancer Prev, 15, 265-71.
과학기술학회마을
DOI
ScienceOn
|
8 |
Zheng YW, Li RM, Zhang XW, et al (2013). Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome. Cancer Invest, 31, 197-205.
DOI
ScienceOn
|
9 |
Savage P, Costelna D, Moore J, et al (1997). A phase II study of continuous infusional 5-fluorouracil and subcutaneous Interleukin-2 (IL-2) in metastatic renal cancer. Eur J Cancer, 33, 1149-51.
DOI
ScienceOn
|
10 |
Holt GE, Podack ER, Raez LE (2011). Immunotherapy as a strategy for the treatment of non-small-cell lung cancer. Therapy, 8, 43-54.
DOI
ScienceOn
|
11 |
Macdonald JS, Astrow AB (2001). Adjuvant therapy of colon cancer. Semin Oncol, 28, 30-40.
DOI
|
12 |
Karre K (2002). NK cells, MHC class I molecules and the missing self. Scand J Immunol, 55, 221-8.
DOI
ScienceOn
|
13 |
Kim JY, Bae JH, Lee SH, et al (2008). Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. J Immunother, 31, 475-86.
DOI
|
14 |
Takiuchi H, Ajani JA (1998). Uracil-tegafur in gastric carcinoma: a comprehensive review. J Clin Oncol, 16, 2877-85.
DOI
|
15 |
Moretta A, Bottino C, Vitale M, et al (2001). Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol, 19, 197-223.
DOI
ScienceOn
|
16 |
Ljunggren HG (2008). Cancer immunosurveillance: NKG2D breaks cover. Immunity, 28, 492-4.
DOI
ScienceOn
|
17 |
Makedonas G, Hutnick N, Haney D, et al (2010). Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog, 6, 1000798.
DOI
ScienceOn
|
18 |
Nausch N, Cerwenka A (2008). NKG2D ligands in tumor immunity. Oncogene, 27, 5944-58.
DOI
ScienceOn
|
19 |
Ahmed Ali HA, Di J, Mei W, et al (2014). Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro. Asian Pac J Cancer Prev, 15, 611-6.
과학기술학회마을
DOI
ScienceOn
|
20 |
Diefenbach A, Raulet DH (1999). Natural killer cells: stress out, turn on, tune in. Curr Biol, 9, 851-3.
DOI
ScienceOn
|
21 |
Gasser S, Orsulic S, Brown EJ, et al (2005). The DNA damage pathway regulates innatemimune system ligands for the NKG2D receptor. Nature, 436, 1186-90.
DOI
ScienceOn
|
22 |
Du G, Ye L, Zhang G, et al (2012). Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN- production. J Cancer Res Clin Oncol, 138, 1727-36.
DOI
ScienceOn
|
23 |
Fearon ER, Pardoll DM, Itaya T, et al (1990). Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60, 397-403.
DOI
ScienceOn
|
24 |
Gaffen SL, Liu KD (2004). Overview of interleukin-2 function, production and clinical applications. Cytokine, 28, 109-23.
DOI
ScienceOn
|
25 |
Gasser S, Raulet DH (2006). Activation and self-tolerance of natural killer cells. Immunol Rev, 214, 130-42.
DOI
ScienceOn
|
26 |
Martinez J, Huang X, Yang Y (2010). Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog, 6, 1000811.
DOI
ScienceOn
|
27 |
Das D, Preet R, Mohapatra P, et al (2013). 1, 3-Bis (2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of Resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells. World J Gastroenterol, 19, 7374-88.
DOI
ScienceOn
|